About Nichepharm
Nichepharm is a Healthcare company based in Gurugram (India) founded in 2019. Injectable pharmaceuticals are developed and manufactured by Nichepharm. The company has 199 employees. Nichepharm has completed 1 acquisition, including Recipharm. Its Indian entity Nichepharm Lifesciences Private Limited reported revenue of ₹217 Cr. Nichepharm offers products and services including Liquid Ampoules, Liquid Vials, Dry Powder Injection, Lyophilized Injection, and Pre-Filled Syringes. Its focus areas include Biopharma Outsourcing, CDMO and Small Molecules & Peptides. Its competitors include Indoco Remedies, Concord Biotech and BDR Pharmaceuticals Internationals; 1 of its 3 listed competitors has raised funding.
Company details
Nichepharm Lifesciences was founded in 2019 in Gurugram, India, as a contract development and manufacturing organization within the pharmaceutical sector. Injectable products, including liquid ampoules, vials, cartridges, and syringes, are produced in specialized units. Global clients are supported through these operations, which build on over 20 years of industry experience focused on quality standards.
- Headquarters Gurugram, India
- Employees 199
- SectorsHealthcare
- Website nichepharm.com
- Social LinkedIn YouTube
- Legal Name Nichepharm Lifesciences Private Limited
- Date of Incorporation 16 Oct, 2019
- Jurisdiction Gurgaon, Haryana, India
Associated legal entities of Nichepharm
Nichepharm operates through Nichepharm Lifesciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Nichepharm Lifesciences Private Limited CIN U24230HR2019PTC083085 | Active | 16 Oct 2019 | Gurgaon, Haryana | ₹217 Cr | 199 | 2 | View details |
Products & Services of Nichepharm
Nichepharm offers a comprehensive portfolio of products and services, including Liquid Ampoules, Liquid Vials, Dry Powder Injection, Lyophilized Injection, and Pre-Filled Syringes.
Manufactures liquid ampoules for pharmaceutical formulations.
Produces liquid vials for various therapeutic applications.
Offers dry powder injections for antibiotics and other uses.
Provides lyophilized injections for stable drug delivery.
Manufactures pre-filled syringes for convenient administration.
Apps and channels of Nichepharm
its YouTube channel Nichepharm Lifesciences has 35 subscribers.
Funding Insights of Nichepharm
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Nichepharm with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2024 | Seed | – | – |
1 investors in total: 1 institutional.
Investors in Nichepharm
Nichepharm has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Recipharm.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Pharmaceutical development and manufacturing services are offered contractually. | 1995 | recipharm.com | Jordbro, Sweden |
Investor details for Nichepharm
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Nichepharm Lifesciences Private Limited (Nichepharm)
Nichepharm Lifesciences Private Limited is the primary company behind Nichepharm. The board of Nichepharm Lifesciences Private Limited currently have 2 directors; the longest-serving is Nitin Sobti, appointed in 2019. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Nitin Sobti DIN 01988793 | Director | 16 Oct 2019 | 7 yrs | Nichepharm Lifesciences Private Limited |
| Chetan Sobti DIN 00906842 | Director | 16 Oct 2019 | 7 yrs | Nichepharm Lifesciences Private Limited |
Financials of Nichepharm
Figures of Nichepharm Lifesciences Private Limited, the primary company behind Nichepharm, for FY 2024. Revenue was ₹217 Cr (+70% year on year). Net profit was ₹47.77 Cr (22% margin). EBITDA was ₹67.09 Cr (31% margin). Revenue has grown at a compounded annual rate of +922% over three years.
- ₹217 CrRevenue · FY 2024 · +70% YoY
- ₹47.77 CrNet profit · 22% margin
- ₹67.09 CrEBITDA · 31% margin
- ₹5.97 CrPaid-up capital
- 199Employees (provident fund records)
- +922%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Nichepharm Lifesciences Private Limited are on its company page.
Detailed financial statements for Nichepharm
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nichepharm
Nichepharm has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Recipharm.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Pharmaceutical development and manufacturing services are offered contractually. | recipharm.com | Jordbro, Sweden | 1995 | Jul 2024 | •••• |
Complete acquisition details for Nichepharm
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Nichepharm
3 dated milestones of Nichepharm across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Nichepharm is founded.
- Acquisition Acquires Recipharm.
- Funding First funding round.
Competitors of Nichepharm
Nichepharm has 3 listed competitors in our database, 1 of them funded. They include Indoco Remedies, Concord Biotech and BDR Pharmaceuticals Internationals.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| indoco.com | 1947 | Mumbai, India | 6,291 | APIs manufacturing and formulation services are provided in therapeutic segments. | ||
| concordbiotech.com | 2000 | Ahmedabad, India | 1,598 | APIs and enzymes are manufactured through fermentation by the CDMO. | ||
| bdrpharma.com | 2003 | Mumbai, India | $88.16M | 1,864 | APIs and finished products are developed and manufactured. |
Detailed competitors of Nichepharm
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Nichepharm (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 2,062 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 548 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 557 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Nichepharm
Complete news archive for Nichepharm
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nichepharm
Nichepharm was founded in 2019 and raised its 1st funding round 5 years after it was founded.
Nichepharm is headquartered in Gurugram, India. It is registered at Gurugram, Haryana, India.
Nichepharm has 199 employees.
The primary company behind Nichepharm, Nichepharm Lifesciences Private Limited, reported revenue of ₹217 Cr for FY 2024, up 70% year on year.
Nichepharm Lifesciences was founded in 2019 in Gurugram, India, as a contract development and manufacturing organization within the pharmaceutical sector. Injectable products, including liquid ampoules, vials, cartridges, and syringes, are produced in specialized units. Global clients are supported through these operations, which build on over 20 years of industry experience focused on quality standards.
Nichepharm's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Indoco Remedies.
Nichepharm offers Liquid Ampoules, Liquid Vials, Dry Powder Injection, Lyophilized Injection, and Pre-Filled Syringes.
Nichepharm has made 1 acquisition, including Recipharm.
Nichepharm has 1 investor. Key investors include Recipharm.
Nichepharm operates through Nichepharm Lifesciences Private Limited.
The legal entities of Nichepharm currently have 2 directors, including Nitin Sobti, Chetan Sobti.